SG11202006994XA - Antibacterial compounds, compositions thereof, and methods using same - Google Patents
Antibacterial compounds, compositions thereof, and methods using sameInfo
- Publication number
- SG11202006994XA SG11202006994XA SG11202006994XA SG11202006994XA SG11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA SG 11202006994X A SG11202006994X A SG 11202006994XA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- same
- antibacterial compounds
- antibacterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862621160P | 2018-01-24 | 2018-01-24 | |
| PCT/US2019/014877 WO2019147753A1 (en) | 2018-01-24 | 2019-01-24 | Antibacterial compounds, compositions thereof, and methods using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202006994XA true SG11202006994XA (en) | 2020-08-28 |
Family
ID=67395668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202006994XA SG11202006994XA (en) | 2018-01-24 | 2019-01-24 | Antibacterial compounds, compositions thereof, and methods using same |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11325920B2 (en) |
| EP (1) | EP3743060A4 (en) |
| AR (1) | AR114309A1 (en) |
| AU (1) | AU2019212241A1 (en) |
| CA (1) | CA3089236A1 (en) |
| SG (1) | SG11202006994XA (en) |
| TW (1) | TW201944989A (en) |
| WO (1) | WO2019147753A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202006994XA (en) | 2018-01-24 | 2020-08-28 | Univ Rockefeller | Antibacterial compounds, compositions thereof, and methods using same |
| GB201812078D0 (en) * | 2018-07-24 | 2018-09-05 | Demuris Ltd | Novel compounds and their uses |
| EP4003200A4 (en) | 2019-07-23 | 2023-08-02 | The Rockefeller University | Antibacterial compounds, compositions thereof, and methods using same |
| WO2021163637A1 (en) | 2020-02-13 | 2021-08-19 | Zymergen Inc. | Metagenomic library and natural product discovery platform |
| WO2021242849A1 (en) * | 2020-05-28 | 2021-12-02 | The Rockefeller University | Antibacterial compounds, compositions thereof, and methods using same |
| CN112051190B (en) * | 2020-09-02 | 2023-08-18 | 重庆科技学院 | Method for evaluating permeability of composite osmotic acid |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5007790A (en) | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
| US5169645A (en) | 1989-10-31 | 1992-12-08 | Duquesne University Of The Holy Ghost | Directly compressible granules having improved flow properties |
| ATE173159T1 (en) | 1992-03-25 | 1998-11-15 | Depomed Systems Inc | ORAL MEDICINAL DOSAGE FORMS BASED ON HYDROXYETHYL CELLULOSE WITH DELAYED RELEASE |
| US5582837A (en) | 1992-03-25 | 1996-12-10 | Depomed, Inc. | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| DK0700399T3 (en) | 1993-05-24 | 2001-11-26 | Lepetit Spa | Derivatives in the 36-position of rifamycins and their use as antimicrobials |
| WO1997047285A1 (en) | 1996-06-10 | 1997-12-18 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| US5972389A (en) | 1996-09-19 | 1999-10-26 | Depomed, Inc. | Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| PT998271E (en) | 1997-06-06 | 2005-10-31 | Depomed Inc | FORMS OF ORAL DOSAGE OF DRUGS WITH GASTRIC RETENTION FOR THE CONTROLLED LIBERATION OF HIGHLY SOLUABLE DRUGS |
| US6635280B2 (en) | 1997-06-06 | 2003-10-21 | Depomed, Inc. | Extending the duration of drug release within the stomach during the fed mode |
| US6323219B1 (en) | 1998-04-02 | 2001-11-27 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for treating immunomediated inflammatory disorders |
| MXPA02004413A (en) | 1999-11-02 | 2002-09-02 | Depomed Inc | Pharmacological inducement of the fed mode for enhanced drug administration to the stomach. |
| MXPA02007254A (en) | 2000-02-04 | 2002-12-09 | Depomed Inc | Shell and core dosage form approaching zero order drug release. |
| US6488962B1 (en) | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| US6451808B1 (en) | 2000-10-17 | 2002-09-17 | Depomed, Inc. | Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists |
| MXPA03011096A (en) | 2001-05-29 | 2004-12-06 | Depomed Dev Ltd | Method of treating gastroesophageal reflux disease and nocturnal acid breakthrough. |
| TWI312285B (en) | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
| CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| US20030091630A1 (en) | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| WO2003035039A1 (en) | 2001-10-25 | 2003-05-01 | Depomed, Inc. | Methods of treatment using a gastric retained losartan dosage |
| US6723340B2 (en) | 2001-10-25 | 2004-04-20 | Depomed, Inc. | Optimal polymer mixtures for gastric retentive tablets |
| US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
| US7247634B2 (en) | 2004-01-13 | 2007-07-24 | Cumbre Pharmaceuticals Inc. | Rifamycin derivatives effective against drug-resistant microbes |
| US9803002B2 (en) | 2013-05-31 | 2017-10-31 | Genentench, Inc. | Anti-wall teichoic antibodies and conjugates |
| MX2017007055A (en) | 2014-12-03 | 2017-11-08 | Genentech Inc | Anti-staphylococcus aureus antibody rifamycin conjugates and uses thereof. |
| SG11202006994XA (en) | 2018-01-24 | 2020-08-28 | Univ Rockefeller | Antibacterial compounds, compositions thereof, and methods using same |
| GB201812078D0 (en) | 2018-07-24 | 2018-09-05 | Demuris Ltd | Novel compounds and their uses |
-
2019
- 2019-01-24 SG SG11202006994XA patent/SG11202006994XA/en unknown
- 2019-01-24 CA CA3089236A patent/CA3089236A1/en active Pending
- 2019-01-24 AR ARP190100161A patent/AR114309A1/en unknown
- 2019-01-24 AU AU2019212241A patent/AU2019212241A1/en not_active Abandoned
- 2019-01-24 US US16/964,317 patent/US11325920B2/en active Active
- 2019-01-24 TW TW108102778A patent/TW201944989A/en unknown
- 2019-01-24 WO PCT/US2019/014877 patent/WO2019147753A1/en unknown
- 2019-01-24 EP EP19744210.6A patent/EP3743060A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019212241A1 (en) | 2020-08-13 |
| CA3089236A1 (en) | 2019-08-01 |
| EP3743060A4 (en) | 2021-11-03 |
| TW201944989A (en) | 2019-12-01 |
| US20210139509A1 (en) | 2021-05-13 |
| US11325920B2 (en) | 2022-05-10 |
| AR114309A1 (en) | 2020-08-19 |
| EP3743060A1 (en) | 2020-12-02 |
| WO2019147753A1 (en) | 2019-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272089A (en) | Compounds, compositions and methods | |
| PL3676297T3 (en) | Compounds, compositions and methods | |
| IL285302A (en) | Compounds, compositions and methods | |
| SG11202006994XA (en) | Antibacterial compounds, compositions thereof, and methods using same | |
| GB201811100D0 (en) | Composition | |
| GB201810492D0 (en) | Composition | |
| GB2576614B (en) | Compositions, uses and methods | |
| IL287120A (en) | Compounds, compositions and methods | |
| GB201812145D0 (en) | Composition | |
| GB201804163D0 (en) | Uses, compositions and methods | |
| GB201804434D0 (en) | Composition | |
| IL261782A (en) | Carbapenem compounds, compositions comprising same and uses thereof | |
| GB2583851B (en) | Composition | |
| GB201818827D0 (en) | Composition | |
| GB201815031D0 (en) | Composition | |
| IL276125A (en) | Dihydroindolizinone derivative compounds, compositions comprising same and uses thereof | |
| IL270505B1 (en) | Compounds, compositions and methods | |
| GB201815032D0 (en) | Composition | |
| GB201809123D0 (en) | Composition | |
| GB201801596D0 (en) | Composition | |
| EP4003200A4 (en) | Antibacterial compounds, compositions thereof, and methods using same | |
| SG11202106754VA (en) | Composition | |
| SG11202105334QA (en) | Composition | |
| GB201913398D0 (en) | Composition | |
| GB201818567D0 (en) | Composition |